These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30037664)

  • 21. Case-Control Study of Rotavirus Vaccine Effectiveness Compared to Test-Negative Controls or Hospital Controls.
    Araki K; Hara M; Shimanoe C; Nishida Y; Matsuo M; Tanaka K
    J Epidemiol; 2019 Aug; 29(8):282-287. PubMed ID: 30344199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era.
    Kozawa K; Higashimoto Y; Kawamura Y; Miura H; Negishi T; Hattori F; Ihira M; Komoto S; Taniguchi K; Yoshikawa T
    Hum Vaccin Immunother; 2022 Dec; 18(1):2037983. PubMed ID: 35240934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of monovalent and pentavalent rotavirus vaccine.
    Cortese MM; Immergluck LC; Held M; Jain S; Chan T; Grizas AP; Khizer S; Barrett C; Quaye O; Mijatovic-Rustempasic S; Gautam R; Bowen MD; Moore J; Tate JE; Parashar UD; Vázquez M
    Pediatrics; 2013 Jul; 132(1):e25-33. PubMed ID: 23776114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
    Doll MK; Buckeridge DL; Morrison KT; Gagneur A; Tapiero B; Charest H; Quach C
    Vaccine; 2015 Dec; 33(51):7307-7314. PubMed ID: 26546262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
    Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
    Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.
    Rahajamanana VL; Raboba JL; Rakotozanany A; Razafindraibe NJ; Andriatahirintsoa EJPR; Razafindrakoto AC; Mioramalala SA; Razaiarimanga C; Weldegebriel GG; Burnett E; Mwenda JM; Seheri M; Mphahlele MJ; Robinson AL
    Vaccine; 2018 Nov; 36(47):7198-7204. PubMed ID: 28958809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.
    Tate JE; Ngabo F; Donnen P; Gatera M; Uwimana J; Rugambwa C; Mwenda JM; Parashar UD
    Clin Infect Dis; 2016 May; 62 Suppl 2():S208-12. PubMed ID: 27059358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of pentavalent rotavirus vaccine against severe disease.
    Staat MA; Payne DC; Donauer S; Weinberg GA; Edwards KM; Szilagyi PG; Griffin MR; Hall CB; Curns AT; Gentsch JR; Salisbury S; Fairbrother G; Parashar UD;
    Pediatrics; 2011 Aug; 128(2):e267-75. PubMed ID: 21768317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis.
    Mohammed A; Immergluck L; Parker TC; Jain S; Leong T; Anderson EJ; Jerris RC
    Vaccine; 2015 Oct; 33(42):5670-5677. PubMed ID: 26322843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.
    Iwata S; Nakata S; Ukae S; Koizumi Y; Morita Y; Kuroki H; Tanaka Y; Shizuya T; Schödel F; Brown ML; Lawrence J
    Hum Vaccin Immunother; 2013 Aug; 9(8):1626-33. PubMed ID: 23732903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia.
    Sanneh B; Papa Sey A; Shah M; Tate J; Sonko M; Jagne S; Jarju M; Sowe D; Taal M; Cohen A; Parashar U; Mwenda JM
    Vaccine; 2018 Nov; 36(47):7179-7184. PubMed ID: 29544688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction.
    Bennett A; Pollock L; Jere KC; Pitzer VE; Parashar U; Tate JE; Heyderman RS; Mwansambo C; French N; Nakagomi O; Iturriza-Gomara M; Everett D; Cunliffe NA; Bar-Zeev N;
    Vaccine; 2018 Nov; 36(47):7142-7148. PubMed ID: 29887320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of rotavirus genotypes associated with acute diarrhoea in Zimbabwean children less than five years old before and after rotavirus vaccine introduction.
    Mukaratirwa A; Berejena C; Nziramasanga P; Ticklay I; Gonah A; Nathoo K; Manangazira P; Mangwanya D; Marembo J; Mwenda JM; Weldegebriel G; Seheri M; Tate JE; Yen C; Parashar U; Mujuru H
    Vaccine; 2018 Nov; 36(47):7248-7255. PubMed ID: 29628149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of rotavirus before and after monovalent rotavirus vaccine introduction and vaccine effectiveness among children in mainland Tanzania.
    Jani B; Hokororo A; Mchomvu J; Cortese MM; Kamugisha C; Mujuni D; Kallovya D; Parashar UD; Mwenda JM; Lyimo D; ; Materu A; Omari KF; Waziri M; Laswai T; Juma H; Mlay J; Dogani J; Stephen E; Seugendo M; Nkumbi U; Lyakurwa A; Matojo A; Bendera E; Senyota J; Msingwa V; Fungo Y; Michael F; Mpamba A; Chambo A; Cholobi H; Lyamuya F; Chami I; Mchome E; Mshana AM; Mushi E; Mariki U; Chard R; Tuju D; Ambokile N; Lukwale F; Kyessi F; Khamis A; Michael I; Macha D; Saguti A
    Vaccine; 2018 Nov; 36(47):7149-7156. PubMed ID: 29655631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of rotavirus vaccines against hospitalisations in Japan.
    Fujii Y; Noguchi A; Miura S; Ishii H; Nakagomi T; Nakagomi O; Takahashi T
    BMC Pediatr; 2017 Jul; 17(1):156. PubMed ID: 28693503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained impact of rotavirus vaccine on rotavirus hospitalisations in Lusaka, Zambia, 2009-2016.
    Mpabalwani EM; Simwaka JC; Mwenda JM; Matapo B; Parashar UD; Tate JE
    Vaccine; 2018 Nov; 36(47):7165-7169. PubMed ID: 29793891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.
    Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N
    BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial.
    Mo Z; Mo Y; Li M; Tao J; Yang X; Kong J; Wei D; Fu B; Liao X; Chu J; Qiu Y; Hille DA; Nelson M; Kaplan SS
    Vaccine; 2017 Oct; 35(43):5897-5904. PubMed ID: 28935470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
    Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
    Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rotavirus Vaccine Effectiveness Against Severe Acute Gastroenteritis: 2009-2022.
    Diallo AO; Wikswo ME; Sulemana I; Sahni LC; Boom JA; Ramani S; Selvarangan R; Moffatt ME; Harrison CJ; Halasa N; Chappell J; Stewart L; Staat MA; Schlaudecker E; Quigley C; Klein EJ; Englund JA; Zerr DM; Weinberg GA; Szilagyi PG; Albertin C; Johnston SH; Williams JV; Michaels MG; Hickey RW; Curns AT; Honeywood M; Mijatovic-Rustempasic S; Esona MD; Bowen MD; Parashar UD; Gautam R; Mirza SA; Tate JE
    Pediatrics; 2024 Oct; 154(4):. PubMed ID: 39252660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.